Thalidomide induced xerosis: an unwanted reaction

Nagesh Kamath, Anurag Shetty, Harneet Singh, Shiran Shetty, Srinivasa Rao Sirasanagandla

Abstract


A 59-year-old male exhibited anemia for evaluation. Endoscopy was diagnostic of gastric antral vascular ectasia. He was given a trial of thalidomide after informing about the adverse effects. After starting thalidomide at 100 mg/day, his hemoglobin (Hb) improved. Post 1 month of therapy his Hb normalized, but he developed xerosis. He was given symptomatic treatment, but did not improve. Thalidomide was suspected to cause xerosis, it was discontinued for a month and post-discontinuation of drug he is symptom free for past 8 months. This paper reports a rare case of thalidomide induced xerosis with dermatological and neurological involvement.


Keywords


Anemia, Gastric antral vascular ectasia, Thalidomide, Xerosis

Full Text:

PDF

References


Park RH, Danesh BJ, Upadhyay R, Howatson AG, Lee FD, Russell RI. Gastric antral vascular ectasia (watermelon stomach) – Therapeutic options. Postgrad Med J. 1990;66(779):720-3.

Toyota M, Hinoda Y, Nakagawa N, Arimura Y, Tokuchi S, Takaoka A, et al. Gastric antral vascular ectasia causing severe anemia. J Gastroenterol. 1996;31(5):710-3.

Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87(5):1165-70.

Selinger CP, Ang YS. Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment. Digestion. 2008;77(2):131-7.

Beers MH, Berkow R. The Merck Manual of Geriatrics. 3rd Edition. Whitehouse Station, NJ: Merck and Co.; 2000: 1247-8.

Balin AK. Aging of human skin. In: Hazzard WR, Andres R, Bierman EL, editors. Principles of Geriatric Medicine and Gerontology. 2nd Edition. New York: McGraw-Hill, Inc.; 1990: 383-412.

Kaplan LA. Xerosis. In: Newcomer VD, Young EM Jr, editors. Geriatric Dermatology: Clinical Diagnosis and Practical Therapy. New York: Igaku-Shoin; 1989: 309-14.

D’Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A. 1994;91(9):4082-5.

Franks ME, Macpherson GR, Figg WD. Thalidomide. Lancet. 2004;363(9423):1802-11.

Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther. 1999;13(11):1429-36.

van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet. 1990;335(8695):953-5.

Manning RJ. Estrogen/progesterone treatment of diffuse antral vascular ectasia. Am J Gastroenterol. 1995;90(1):154-6.

McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42(5):750-2.

Woo KS, Tse LK, Woo JL, Vallance-Owen J. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract. 1989;43(12):465-6.

Lorenzi AR, Johnson AH, Davies G, Gough A. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide. Ann Rheum Dis. 2001;60(8):796-8.